๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Cumulative cognitive impairment following recurrent severe hypoglycaemia in adult patients with insulin-treated diabetes mellitus

โœ Scribed by S. J. Langan; I. J. Deary; D. A. Hepburn; B. M. Frier


Publisher
Springer
Year
1991
Tongue
English
Weight
876 KB
Volume
34
Category
Article
ISSN
0012-186X

No coin nor oath required. For personal study only.

โœฆ Synopsis


To examine the hypothesis that episodes of severe hypogtycaemia may cause cumulative cognitive impairment, 100 Type 1 (insulin-dependent) diabetic patients were examined. Their age range was 25-52 years, and the onset of diabetes had occurred after the age of 19 years. Patients with evidence of organic brain disease, including cerebrovascular disease, were excluded. A questionnaire was used to assess the number, frequency and severity of hypoglycaemic episodes experienced during treatment with insulin and the accuracy of this retrospective information was verified from general practice and hospital case-notes. A detailed neuropsychological assessment was undertaken, including tests of pre-morbid and present IQ (Wechsler-Revised), memory and information-processing speed. Significant correlations were observed between the frequency of severe hypoglycaemia and the magnitude of intellectual decline, Performance IQ, inspection time and reaction time (patients with the more frequent hypoglycaemia had poorer performance). Two sub-groups of patients were identified on the basis of their experience of severe hypoglycaemia, and were balanced for pre-morbid IQ, age and duration of diabetes. One sub-group (n = 23) had never experienced severe hypoglycaemia (Group A), whilst the other sub-group (n = 24) had suffered at least five episodes of severe hypoglycaemia (Group B). Group B had greater intellectual impairment than Group A, and Group B also had a significantly slower mean reaction time and higher reaction time variance when compared with Group A. It is concluded that recurrent severe hypoglycaemia is associated with cumulative cognitive impairment in adult diabetic patients treated with insulin.


๐Ÿ“œ SIMILAR VOLUMES


Evaluation of serum markers of neuronal
โœ Mark W.J. Strachan; Hagosa D. Abraha; Roy A. Sherwood; G. Alistair Lammie; Ian J ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 288 KB ๐Ÿ‘ 1 views

Background Neurone-speciยฎc enolase (NSE) and protein S-100 (S-100) may be used as markers of acute neuronal damage in humans with neurological disorders. Method To evaluate their use following a single episode of severe hypoglycaemia (deยฎned as an episode requiring external assistance to aid recove